News of the WeekHIV/AIDS

At Last, Vaginal Gel Scores Victory Against HIV

Science  23 Jul 2010:
Vol. 329, Issue 5990, pp. 374-375
DOI: 10.1126/science.329.5990.374

You are currently viewing the summary.

View Full Text

Via your Institution

Log in through your institution

Log in through your institution


Summary

For the first time ever, a vaginal gel has unequivocally blocked the transmission of HIV. In a trial that involved nearly 900 South African women, those who received a vaginal gel that contains an anti-HIV drug had a 39% lower chance of becoming infected by the virus than those who received a placebo. As reported online this week in Science and in a presentation at the 18th International AIDS Conference in Vienna, of the 444 women who received a placebo gel, 60 became infected with HIV versus 38 infections in the 445 women who received the microbicide. The result was statistically significant, and no serious side effects occurred.

Related Content